Switzerland

June 2021 Edition

Interviews
Anne Lévy
director-general, FOPH

As part of the Federal Department of Home Affairs, the Federal Office of Public Health (FOPH) is responsible for public health in Switzerland; developing the country’s health policy and working to create an efficient and affordable healthcare system in the long term.

René P Buholzer
CEO, Interpharma, Switzerland

Interpharma’s Dr René P. Buholzer highlights the key lessons that Switzerland’s innovative pharmaceutical industry has taken from the COVID-19 pandemic, the challenges inherent in the country’s two upcoming cost contain…

Anne Lévy
director-general, FOPH

As part of the Federal Department of Home Affairs, the Federal Office of Public Health (FOPH) is responsible for public health in Switzerland; developing the country’s health policy and working to create an efficient and affordable healthcare system in the long term.

René P Buholzer
CEO, Interpharma, Switzerland

Interpharma’s Dr René P. Buholzer highlights the key lessons that Switzerland’s innovative pharmaceutical industry has taken from the COVID-19 pandemic, the challenges inherent in the country’s two upcoming cost contain…

Read the Full Version
Remo Gujer
General Manager, BMS Switzerland & Austria

Dr Remo Gujer gives an overview of the BMS footprint in Switzerland and Austria, the ongoing integration of legacy Celgene operations, market access challenges, clinical trials…

Thomas F. Schmidt
Managing Director, Roche Pharma Switzerland

Thomas F. Schmidt, country manager of Roche Pharma in its home market of Switzerland discusses adjusting to his first role in general management…

Remo Gujer
General Manager, BMS Switzerland & Austria

Dr Remo Gujer gives an overview of the BMS footprint in Switzerland and Austria, the ongoing integration of legacy Celgene operations, market access challenges, clinical trials…

Thomas F. Schmidt
Managing Director, Roche Pharma Switzerland

Thomas F. Schmidt, country manager of Roche Pharma in its home market of Switzerland discusses adjusting to his first role in general management…

Susan M. Gasser
Director Emeritus & Group Leader, Friedrich Miescher Institute for Biomedical Research (FMI), Switzerland

Professor Susan M. Gasser, now director and group leader emeritus…

Ans Heirman
AVP Managing Director, MSD Switzerland

Switzerland is a crucial country for MSD’s global network, employing over 1000 people in local, regional, and global functions across four sites in Lucerne and a newly opened site in…

Christiane von der Eltz
Country Speaker, Merck Switzerland

Merck Switzerland’s Christiane von der Eltz highlights the German firm’s recent big investments in Switzerland and how it forms a key part of Mer…

Susan M. Gasser
Director Emeritus & Group Leader, Friedrich Miescher Institute for Biomedical Research (FMI), Switzerland

Professor Susan M. Gasser, now director and group leader emeritus…

Ans Heirman
AVP Managing Director, MSD Switzerland

Switzerland is a crucial country for MSD’s global network, employing over 1000 people in local, regional, and global functions across four sites in Lucerne and a newly opened site in…

Christiane von der Eltz
Country Speaker, Merck Switzerland

Merck Switzerland’s Christiane von der Eltz highlights the German firm’s recent big investments in Switzerland and how it forms a key part of Mer…

Katharina Gasser
Managing Director, Biogen Switzerland

Biogen Switzerland’s Dr med Katharina Gasser outlines how her affiliate navigated the COVID-19 pandemic from an organisational and communication perspective, the increasing importance being given…

Vincent Gruntz
General Manager Oncology, Novartis Pharma Switzerland

Vincent Gruntz looks at the market dynamics for oncology in Switzerland, where an increasingly cost-conscious approach is being taken to reimbursement and pricing, his…

Miro Venturi
CEO, Sintetica

Dr Miro Venturi of Swiss injectable anaesthetics and analgesics specialist Sintetica outlines his career journey, why personalised medicine is about taking a holistic view across the entire patient journey, and the growth strategy he has set out for the com…

Katharina Gasser
Managing Director, Biogen Switzerland

Biogen Switzerland’s Dr med Katharina Gasser outlines how her affiliate navigated the COVID-19 pandemic from an organisational and communication perspective, the increasing importance being given…

Vincent Gruntz
General Manager Oncology, Novartis Pharma Switzerland

Vincent Gruntz looks at the market dynamics for oncology in Switzerland, where an increasingly cost-conscious approach is being taken to reimbursement and pricing, his…

Miro Venturi
CEO, Sintetica

Dr Miro Venturi of Swiss injectable anaesthetics and analgesics specialist Sintetica outlines his career journey, why personalised medicine is about taking a holistic view across the entire patient journey, and the growth strategy he has set out for the com…

Antonella Santuccione Chadha
CEO pro-bono, Women’s Brain Project & Head of Stakeholder Engagement for Alzheimer’s Disease, Biogen

Antonella Santuccione Chadha*, Head of Stakeholder Engagement…

Jan Tangermann
Country Head, Sandoz Switzerland

Sandoz Switzerland’s Jan Tangermann highlights the importance of the Swiss affiliate to the global group and how it was able to provide sustainable and reliable access to critical and essential medicines duri…

Chris Martin
CEO, Co-Founder and Director, ADC Therapeutics

Dr Chris Martin, CEO and co-founder of Swiss-headquartered antibody-drug conjugate cancer company, ADC Therapeutics, shares the company’s journey over the past de…

Antonella Santuccione Chadha
CEO pro-bono, Women’s Brain Project & Head of Stakeholder Engagement for Alzheimer’s Disease, Biogen

Antonella Santuccione Chadha*, Head of Stakeholder Engagement…

Jan Tangermann
Country Head, Sandoz Switzerland

Sandoz Switzerland’s Jan Tangermann highlights the importance of the Swiss affiliate to the global group and how it was able to provide sustainable and reliable access to critical and essential medicines duri…

Chris Martin
CEO, Co-Founder and Director, ADC Therapeutics

Dr Chris Martin, CEO and co-founder of Swiss-headquartered antibody-drug conjugate cancer company, ADC Therapeutics, shares the company’s journey over the past de…

Marcel Platiner
President, vips

Marcel Plattner, president of Swiss industry association vips discusses pricing, market access and innovation, as well as the continuing attractiveness of Switzerland as a pharmaceutical investment destination.

Jacques Marbehant
Senior Vice President, Head of Global Manufacturing, Engineering and Health, Safety & Environment, UCB

Belgian champion UCB’s global manufacturing head, Jacques Marbehant, talks candidly about managing a broad global manufact… 

Laurent Massuyeau
CEO, iQone Healthcare, Switzerland

Laurent Massuyeau introduces Swiss biosimilar commercialisation specialist iQone healthcare, why it made sense to base the company in Switzerland, its partnership deal with Korean biosimilar giant Celltrion, and wher…

Marcel Platiner
President, vips

Marcel Plattner, president of Swiss industry association vips discusses pricing, market access and innovation, as well as the continuing attractiveness of Switzerland as a pharmaceutical investment destination.

Jacques Marbehant
Senior Vice President, Head of Global Manufacturing, Engineering and Health, Safety & Environment, UCB

Belgian champion UCB’s global manufacturing head, Jacques Marbehant, talks candidly about managing a broad global manufact… 

Laurent Massuyeau
CEO, iQone Healthcare, Switzerland

Laurent Massuyeau introduces Swiss biosimilar commercialisation specialist iQone healthcare, why it made sense to base the company in Switzerland, its partnership deal with Korean biosimilar giant Celltrion, and wher…

Luis Iglesias
President & Head of EMEA, Santen

Santen is a leading multinational company that specializes in ophthalmology. President and Head for Europe, Middle East and Africa (EMEA) Luis Iglesias highlights the company’s recent transformation…

Antonio Francesco di Naro
President & Founder, ADIENNE

Swiss-headquartered ADIENNE has made recent headlines after being announced as the first European company to manufacture Russia’s Sputnik V COVID-19 vaccine.

Marc-Olivier Geinoz
CEO, Dipharma SA

Dipharma SA is a Swiss specialty pharmaceutical company, developing improved generics medicines for rare metabolic diseases. Founder & CEO Marc-Olivier Geinoz discusses why the company has chosen to compe…

Luis Iglesias
President & Head of EMEA, Santen

Santen is a leading multinational company that specializes in ophthalmology. President and Head for Europe, Middle East and Africa (EMEA) Luis Iglesias highlights the company’s recent transformation…

Antonio Francesco di Naro
President & Founder, ADIENNE

Swiss-headquartered ADIENNE has made recent headlines after being announced as the first European company to manufacture Russia’s Sputnik V COVID-19 vaccine.

Marc-Olivier Geinoz
CEO, Dipharma SA

Dipharma SA is a Swiss specialty pharmaceutical company, developing improved generics medicines for rare metabolic diseases. Founder & CEO Marc-Olivier Geinoz discusses why the company has chosen to compe…

Katrien de Vos
Country President, AstraZeneca Switzerland

AstraZeneca’s recently arrived Switzerland country president, Katrien de Vos, gives her first impressions of the Swiss market and how she hopes to build upon the affiliate’s strong…

Tero Silvola
CEO, BC Platforms

CEO Tero Silvola introduces BC Platforms’ powerful data and technology platform for personalized medicine and drug development and the ‘infinity loop’ between the interconnected sectors of healthcare and life sciences that the company…

Eric ten Kate
Vice President, Global Life Science, Agility

Eric ten Kate, VP for Global Life Science at logistics and distribution firm Agility, highlights how the company responded to the unprecedented challenges thrown up by the COVID-19 pandemic and…

Katrien de Vos
Country President, AstraZeneca Switzerland

AstraZeneca’s recently arrived Switzerland country president, Katrien de Vos, gives her first impressions of the Swiss market and how she hopes to build upon the affiliate’s strong…

Tero Silvola
CEO, BC Platforms

CEO Tero Silvola introduces BC Platforms’ powerful data and technology platform for personalized medicine and drug development and the ‘infinity loop’ between the interconnected sectors of healthcare and life sciences that the company…

Eric ten Kate
Vice President, Global Life Science, Agility

Eric ten Kate, VP for Global Life Science at logistics and distribution firm Agility, highlights how the company responded to the unprecedented challenges thrown up by the COVID-19 pandemic and…

Michael Hübner
New Venture Lead, Johnson & Johnson Innovation Switzerland

Johnson & Johnson Innovation focuses on accelerating all stages of innovation worldwide, forming collaborations between entrepreneurs and the Johnson & Johnson Family…

Thomas A. Tóth von Kiskér
CEO & Board Member, Tillotts Pharma AG

Thomas A. Tóth von Kiskér, longstanding CEO of Tillotts Pharma AG, a Switzerland-based specialty pharma player focused on the digestive system, shares his M&A…

Georg Boonen
CEO, Max Zeller

Georg Boonen, CEO of Switzerland’s leading phytopharmaceutical player Max Zeller, discusses the company’s expanded market position at home and abroad, how COVID-19 and a reconsideration of preventive healthcare could be an inflection…

Michael Hübner
New Venture Lead, Johnson & Johnson Innovation Switzerland

Johnson & Johnson Innovation focuses on accelerating all stages of innovation worldwide, forming collaborations between entrepreneurs and the Johnson & Johnson Family…

Thomas A. Tóth von Kiskér
CEO & Board Member, Tillotts Pharma AG

Thomas A. Tóth von Kiskér, longstanding CEO of Tillotts Pharma AG, a Switzerland-based specialty pharma player focused on the digestive system, shares his M&A…

Georg Boonen
CEO, Max Zeller

Georg Boonen, CEO of Switzerland’s leading phytopharmaceutical player Max Zeller, discusses the company’s expanded market position at home and abroad, how COVID-19 and a reconsideration of preventive healthcare could be an inflection…

Bertrand Ducrey
CEO, Debiopharm

In a wide-ranging interview CEO Bertrand Ducrey introduces Debiopharm’s unique business focus on drug improvement, drug delivery, and drug targeting; recent progress in oncology, including an FDA breakthrough designation and ou…

Pius Zängerle
Director, curafutura, Switzerland

Pius Zängerle of curafutura, one of the two largest Swiss health insurers’ associations, explains the unique Swiss health insurance ecosystem and the main issues on his agenda for 2021 beyond the global pandemic…

Nicolas Fischer
CEO, Light Chain Bioscience

Dr Nicolas Fischer introduces Light Chain Bioscience, a Swiss biotech company focusing on the discovery and development of bispecific antibodies using proprietary technology. Fischer also outlines th…

Bertrand Ducrey
CEO, Debiopharm

In a wide-ranging interview CEO Bertrand Ducrey introduces Debiopharm’s unique business focus on drug improvement, drug delivery, and drug targeting; recent progress in oncology, including an FDA breakthrough designation and ou…

Pius Zängerle
Director, curafutura, Switzerland

Pius Zängerle of curafutura, one of the two largest Swiss health insurers’ associations, explains the unique Swiss health insurance ecosystem and the main issues on his agenda for 2021 beyond the global pandemic…

Nicolas Fischer
CEO, Light Chain Bioscience

Dr Nicolas Fischer introduces Light Chain Bioscience, a Swiss biotech company focusing on the discovery and development of bispecific antibodies using proprietary technology. Fischer also outlines th…

Susanne Caspar
CEO, Linnea

Susanne Caspar, CEO at Swiss natural API producer Linnea, talks about her first few months in the company, the pharmaceutical industry’s growing embrace of natural ingredients, and why Linnea has made the move into cannabis API…

Stefan Berg
General Manager, Pharmaplan AG Switzerland

Stefan Berg, general manager of Pharmaplan, one of the leading pharma engineering partners in Europe, outlines the key trends in this area, including an expected invest…

Lorenzo Ambrosini
CEO, Agire Foundation, Switzerland

Lorenzo Ambrosini of the Agire Foundation introduces the major new innovation projects underway in the Italian-speaking Swiss canton of Ticino; the canton’s strong existing footprint in bioinformatics, AI, and…

Susanne Caspar
CEO, Linnea

Susanne Caspar, CEO at Swiss natural API producer Linnea, talks about her first few months in the company, the pharmaceutical industry’s growing embrace of natural ingredients, and why Linnea has made the move into cannabis API…

Stefan Berg
General Manager, Pharmaplan AG Switzerland

Stefan Berg, general manager of Pharmaplan, one of the leading pharma engineering partners in Europe, outlines the key trends in this area, including an expected invest…

Lorenzo Ambrosini
CEO, Agire Foundation, Switzerland

Lorenzo Ambrosini of the Agire Foundation introduces the major new innovation projects underway in the Italian-speaking Swiss canton of Ticino; the canton’s strong existing footprint in bioinformatics, AI, and…

Giorgio Calderari
Chairman, Farma Industria Ticino (FIT), Switzerland

Giorgio Calderari, the chairman of Farma Industria Ticino, the association of chemical and pharmaceutical industries in the Swiss canton of Ticino, explains how a region with a…

Andrea Emilio Rizzoli
Director, Dalle Molle Institute for Artificial Intelligence (IDSIA USI-SUPSI), Switzerland

Andrea Emilio Rizzoli of the Dalle Molle Institute for Artificial Intellige…

Michael Altorfer
CEO, Swiss Biotech Association

Michael Altorfer, CEO of the Swiss Biotech Association, a membership organisation representing the interests of the Swiss biotech industry, discusses the evolution of the biotech sector in Switzerland, how the cou…

Giorgio Calderari
Chairman, Farma Industria Ticino (FIT), Switzerland

Giorgio Calderari, the chairman of Farma Industria Ticino, the association of chemical and pharmaceutical industries in the Swiss canton of Ticino, explains how a region with a…

Andrea Emilio Rizzoli
Director, Dalle Molle Institute for Artificial Intelligence (IDSIA USI-SUPSI), Switzerland

Andrea Emilio Rizzoli of the Dalle Molle Institute for Artificial Intellige…

Michael Altorfer
CEO, Swiss Biotech Association

Michael Altorfer, CEO of the Swiss Biotech Association, a membership organisation representing the interests of the Swiss biotech industry, discusses the evolution of the biotech sector in Switzerland, how the cou…

Jean-Paul Clozel
CEO, Idorsia

In an exclusive interview, Jean-Paul Clozel explains Idorsia’s unique value proposition as a biotech focused on small molecules, how agnosticism in terms of therapeutic areas leads to more innovative medical…

Jon Helsdingen
General Manager, AbbVie Switzerland

AbbVie Switzerland’s Jon Helsdingen outlines how he has led the Swiss affiliate through a full scale office move, the acquisition and integration of Allergan and the COVID-19…

Stephan Mumenthaler
Director General, scienceindustries, Switzerland

scienceindustries’ Stephan Mumenthaler outlines the business-friendly regulation necessary to…

Jean-Paul Clozel
CEO, Idorsia

In an exclusive interview, Jean-Paul Clozel explains Idorsia’s unique value proposition as a biotech focused on small molecules, how agnosticism in terms of therapeutic areas leads to more innovative medical…

Jon Helsdingen
General Manager, AbbVie Switzerland

AbbVie Switzerland’s Jon Helsdingen outlines how he has led the Swiss affiliate through a full scale office move, the acquisition and integration of Allergan and the COVID-19…

Stephan Mumenthaler
Director General, scienceindustries, Switzerland

scienceindustries’ Stephan Mumenthaler outlines the business-friendly regulation necessary to…

Thanks for reading!

The Digital Version of the Healthcare & Life Sciences Review: Switzerland is available and optimized for desktop browsers.

Visit our website with your computer or download the pdf report

Read the Full Version

2021. Healthcare & Life Sciences Review was produced by Pharmaboardroom.

Copyright: All rights reserved. No part of this publication maybe reproduced in any form or by any means, whether electronic, mechanical or otherwise including photocopying, recording or any information storage or retrieval system without prior written consent of PharmaBoardroom. While every attempt is made to ensure the accuracy of the information contained in this report, neither PharmaBoardroom nor the authors accept any liabilities forerrors and omissions. Opinions expressed in this report are not necessarily those of the authors. All the images belongs to its respective authors.

Report Director: Carla Verdera
Senior Editor: Patrick Burton, Louis Haynes
Publisher: Diana Viola
Graphic Designer: Miriam León

PharmaBoardroom

Contact us

+44 20 7867 3717 info@pharmaboardroom.com

For media inquiries, please contact: media@pharmaboardroom.com

Address

PharmaBoardroom Limited Lynton House, 7-12, Tavistock Square, London, United Kingdom, WC1H 9LT

Subscribe